ACTIVE

THERACELL ADVANCED BIOTECHNOLOGY (Belgium)

Financial year 2022 · closed on 31/12/2022
Net result
-128,3 k €
-91.9% YoY
Gross margin
-37,2 k €
-272.8% YoY
Equity
-179,1 k €
-252.8% YoY

What does THERACELL ADVANCED BIOTECHNOLOGY (Belgium) do?

THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is a Private limited company incorporated in 2019. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Marche-en-Famenne.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0731.712.273
Incorporation
30/07/2019
Legal form
Private limited company
Registered office
Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2022
Joint committees (1)
  • 207
Contacts
1 public detail availableLog in to view
Signals
Good liquidityHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202220212020
Income statement
Gross margin-37,2 k €-10,0 k €-1,8 k €
EBITDA-127,4 k €-66,2 k €-2,5 k €
Operating result-127,4 k €-66,2 k €-2,5 k €
Net result-128,3 k €-66,9 k €-2,5 k €
Balance sheet
Equity-179,1 k €-50,8 k €16,1 k €
Total assets327,8 k €456,9 k €216,1 k €
Cash206,6 k €455,8 k €215,9 k €
Debts506,9 k €507,6 k €200,0 k €
Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active

Active mandates

Fotios Sakellaridis

Director

Active
At this address

Other companies at this address

CompanyCBE no.
AGRICELLSActive
0742.991.393
0416.914.413
0457.901.762
0863.356.814
0677.980.015
1031.100.991
CER-GroupeActive
0420.654.158
1008.960.841
0540.866.555
0790.353.624
RevaTisActive
0541.682.642
REVATIS VETActive
1015.868.627
Annual accounts

Full financial information

202220212020
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202201/01/202129/07/2019
Closing of the financial year31/12/202231/12/202131/12/2020
Length of the financial year12 months12 months18 months
Filing date14/07/202322/08/202230/09/2021
General meeting02/05/202302/05/202203/05/2021
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202202/05/202314/07/2023FrenchPDF
Micro model31/12/202102/05/202222/08/2022FrenchPDF
Micro model31/12/202003/05/202130/09/2021FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active

Active mandates

Fotios Sakellaridis

Director

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office18/04/2023
    SIEGE SOCIAL
    PDF
  • Other01/08/2019
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2022
    Annual accounts 2022-128,3 k €
  2. 2021
    Annual accounts 2021-66,9 k €
  3. 2020
    Annual accounts 2020-2,5 k €
  4. 30/07/2019
    IncorporationPrivate limited company